98%
921
2 minutes
20
Objective: To evaluate the factors associated with complete myomectomy in a single surgical procedure and the aspects related to the early complications.
Methods: A cross-sectional study with women with submucous myomas. The dependent variables were the complete myomectomy performed in a single hysteroscopic procedure, and the presence of early complications related to the procedure.
Results: We identified 338 women who underwent hysteroscopic myomectomy. In 89.05% of the cases, there was a single fibroid to be treated. According to the classification of the International Federation of Gynecology and Obstetrics (Fédération Internationale de Gynécologie et d'Obstétrique, FIGO, in French), most fibroids were of grade 0 (66.96%), followed by grade 1 (20.54%), and grade 2 (12.50%). The myomectomies were complete in 63.31% of the cases, and the factors independently associated with complete myomectomy were the diameter of the largest fibroid (prevalence ratio [PR]: 0.97; 95% confidence interval [95%CI]: 0.96-0.98) and the classification 0 of the fibroid according to the FIGO (PR: 2.04; 95%CI: 1.18-3.52). We observed early complications in 13.01% of the hysteroscopic procedures (4.44% presented excessive bleeding during the procedure, 4.14%, uterine perforation, 2.66%, false route, 1.78%, fluid overload, 0.59%, exploratory laparotomy, and 0.3%, postoperative infection). The only independent factor associated with the occurrence of early complications was incomplete myomectomy (PR: 2.77; 95%CI: 1.43-5.38).
Conclusions: Our results show that hysteroscopic myomectomy may result in up to 13% of complications, and the chance of complete resection is greater in small and completely intracavitary fibroids; women with larger fibroids and with a high degree of myometrial penetration have a greater chance of developing complications from hysteroscopic myomectomy.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309217 | PMC |
http://dx.doi.org/10.1055/s-0040-1713915 | DOI Listing |
Hum Reprod Update
September 2025
Women's Health Research Collaborative, New York, NY, USA.
Background: Reproductive-age women with intrauterine adhesions (IUAs) following uterine surgery may be asymptomatic or may experience light or absent menstruation, infertility, preterm delivery, and/or peripartum hemorrhage. Understanding procedure- and technique-specific risks and the available evidence on the impact of surgical adjuvants is essential to the design of future research.
Objective And Rationale: While many systematic reviews have been published, most deal with singular aspects of the problem.
Eur J Obstet Gynecol Reprod Biol
August 2025
Hospital Universitario San Jorge - Jaca, Huesca, Spain. Electronic address:
Objective: To evaluate transvaginal radiofrequency ablation (TRFA) as a preoperative strategy to facilitate hysteroscopic resection in patients with complex submucosal fibroids desiring uterine preservation.
Design: Prospective case series.
Setting: Single tertiary hospital (Puerta de Hierro University Hospital, Madrid, Spain), January 2021-June 2023.
Int J Gynaecol Obstet
July 2025
Department of Gynecology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Cureus
August 2025
Obstetrics and Gynecology, Health and Medical Services (HMS) Al Garhoud Hospital, Dubai, ARE.
The management of symptomatic uterine fibroids depends on various factors, including patient preferences and individual considerations. The management options are multimodal, including medical and surgical therapies. In this report, we present the case of a 33-year-old female patient with submucosal uterine fibroids managed through laparoscopic myomectomy, chosen over hysteroscopic myomectomy based on the patient's specific preferences and clinical indications.
View Article and Find Full Text PDFMod Pathol
August 2025
Department of Bio-Pathology, Institut Bergonié, Bordeaux, France; Inserm U1312, Université de Bordeaux, Bordeaux, France.
The advent of widespread genomic testing of uterine mesenchymal tumors has led to novel insights into the biology of these diverse tumors, and many genomically-defined entities have been described in recent years. During a larger study of endometrial stromal sarcomas and unclassified uterine sarcomas, we identified three tumors harboring KDM2B gene fusions. Patients were 32, 61, and 67 years old and all initially underwent incomplete sampling via laparoscopic myomectomy (n=1), laparoscopic biopsy (n=1), or hysteroscopic myomectomy (n=1).
View Article and Find Full Text PDF